Skip to content

A Study on the Application of Aromatherapy Combined With Transcranial Magnetic Stimulation in Insomnia of Stroke Patients

A Study on the Application of Aromatherapy Combined With Transcranial Magnetic Stimulation in Insomnia of Stroke Patients

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07202806
Enrollment
6
Registered
2025-10-02
Start date
2025-10-08
Completion date
2026-12-31
Last updated
2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Brief summary

Exploring the application efficacy of aromatherapy combined with transcranial magnetic stimulation on insomnia in patients with cerebral stroke

Interventions

BEHAVIORALAromatherapy

1.Aromatherapy is made from self-made sachet of traditional Chinese medicine.Its components (albizzia, Angelica dahurica, cardamom, Polygala, Evodia, Magnolia, Acorus calamus) are 10g each. Place the pillow 1 hour in advance. It is forbidden to play with your mobile phone or turn off the lights before going to bed.

Sponsors

Dandan Wu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
24 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of stroke * Insomnia patients * Sign the informed consent form, cooperate voluntarily * Accord with the diagnosis of insomnia in traditional Chinese medicine * Evaluation has no taboo on transcranial magnetism * The age range is between 24 and 65

Exclusion criteria

* Disturbance of consciousness * Cognitive impairment * Mental abnormality * Sleep apnea syndrome * Restless leg syndrome

Design outcomes

Primary

MeasureTime frameDescription
Respiratory sleep monitoringFrom enrollment to the end of treatment for 3 weeksThe average length of sleep in a week Sleep breathing monitoring was determined by evaluation before and after treatment. The main purpose of this study was to observe whether the average sleep time of patients increased significantly after treatment.

Secondary

MeasureTime frameDescription
Pittsburgh sleep quality index,PSQIFrom enrollment to the end of treatment for 3 weeksPittsburgh sleep quality index(PSQI) The Pittsburgh Sleep quality Index (PSQI) was used to evaluate the sleep status of the patients before treatment and after three weeks of treatment. The total score of the scale was 0-21. The higher the score, the worse the sleep quality.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026